Lipella Pharmaceuticals LIPO
LIPO
$0.00 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Lipella Pharmaceuticals Inc. (LIPO) Receivables (2022 - 2024)

Updated

Lipella Pharmaceuticals (LIPO) reported Receivables of $169,426 for Q4 2024, up 424.8% from $32,286 a year earlier and up 445.1% from the prior quarter.

Analysis

Lipella Pharmaceuticals Inc. (LIPO) Receivables (2022 - 2024) Analysis & Trends

Dating back to Q4 2022, Lipella Pharmaceuticals' Receivables record includes 9 quarters.

  • By year, Receivables came in at $32,286 in FY2023 (-71.6%) and $113,655 in FY2022.
  • The Q4 2024 figure ranks as the highest quarterly Receivables in data going back to Q4 2022.
  • Year over year, Receivables gained in two of the last five quarters, with growth averaging 63.9%.
  • Per Business Quant data, the three quarters before Q4 2024 came in at $31,079 (Q3 2024), $35,332 (Q2 2024) and $68,934 (Q1 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 169,426.00
Sep 30, 2024 31,079.00
Jun 30, 2024 35,332.00
Mar 31, 2024 68,934.00
Dec 31, 2023 32,286.00
Sep 30, 2023 53,140.00
Jun 30, 2023 28,044.00
Mar 31, 2023 83,967.00
Dec 31, 2022 113,655.00
API Access

Lipella Pharmaceuticals Inc. Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=LIPO&period=max&api_key=YOUR_API_KEY